Biospective provides end-to-end solutions for clinical studies. From single site, exploratory/early phase studies to large-scale, multi-center imaging and digital biomarker studies, Biospective provides industry-leading expertise and services.
Comprehensive support for Phase Ib-III multi-center studies using multi-modality imaging (MRI, PET, SPECT).
Turnkey solutions providing everything from patient recruitment to MRI / PET / SPECT scanning, neurological / neuropsychiatric exams, sleep lab testing, and gait / posture / balance assessments.
From validation of novel technologies to deployment of digital health solutions in large, multi-center studies, Biospective is leading the way in the digital biomarker revolution.